Sharechat Logo

Ryman appoints Chief Strategy Officer

Tuesday 4th April 2023

Text too small?

Ryman announced today that David (Dave) Bennett, currently the Group Chief Financial Officer, has been appointed as Chief Strategy Officer for the group.

 

Dave has been instrumental in the successful execution of our recent capital raise, and the development of the strategy that underpins it. He has very strong relationships internally and externally, and an in-depth knowledge of the business and the sector.

 

Group CEO Richard Umbers commented, “I am thrilled that Dave has accepted this role, he is well positioned to drive the execution and evolution of the Ryman strategy”.

 

Dave will continue in his current position until a successor has been appointed as Group CFO. An external search will commence shortly.

 

About Dave Bennett:

Dave joined Ryman in 2013 and was promoted to Group Chief Financial Officer in 2017. He is a board member of the Retirement Villages Association of New Zealand and the New Zealand Aged Care Association. Dave has a Bachelor of Commerce and is a

chartered accountant. Before joining Ryman, he worked as an accountant and auditor.

 

Contact:

For any enquiries, please contact Di Walsh, Chief People and Safety Officer, on +64 27 205 6254 or email di.walsh@rymanhealthcare.com



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Devon Funds Morning Note - 11 March 2026
BGP - Full Year Results to 25 January 2026
BRM - Scheme of Arrangement Update - NZ Commerce Commission
The oil shock
Air New Zealand suspends FY2026 guidance
March 10th Morning Report
FSF - Mainland Group sale unconditional
TRU - Study Confirms Superiority of TruScreen+hr-HPV co-testing
March 9th Morning Report
March 6th Morning Report